A pilot study of PLX3397, a selective colony-stimulating factor 1 receptor (CSF1R) kinase inhibitor, in pigmented villonodular synovitis (PVNS).
William D. Tap
Consultant or Advisory Role - Plexxikon
Research Funding - Plexxikon
Stephen Patrick Anthony
Research Funding - Plexxikon
Bartosz Chmielowski
Consultant or Advisory Role - Bristol-Myers Squibb; CytRx Corporation; Genentech; GlaxoSmithKline
Honoraria - Bristol-Myers Squibb; Genentech; Prometheus
Research Funding - Plexxikon
Arthur P. Staddon
Research Funding - Plexxikon
Allen Lee Cohn
Research Funding - Plexxikon
Geoffrey Shapiro
Research Funding - Plexxikon
Igor Puzanov
Consultant or Advisory Role - Daiichi Sankyo
Research Funding - Plexxikon
Eunice L Kwak
Research Funding - Plexxikon
Andrew J Wagner
Consultant or Advisory Role - Novartis; Plexxikon
Research Funding - Plexxikon
Charles Peterfy
Employment or Leadership Position - Spire Sciences, Inc.
Stock Ownership - Spire Sciences, Inc.
Henry H Hsu
Consultant or Advisory Role - Plexxikon
Carolyn Gee
Consultant or Advisory Role - Plexxikon
Paul S. Lin
Employment or Leadership Position - Plexxikon
Sandra Tong
Employment or Leadership Position - Plexxikon
Zev A. Wainberg
Research Funding - Plexxikon